Gadde, Kishore M.

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

Gadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 1,064

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study

Garvey, W. T., Ryan, D. H., Look, M., Gadde, K. M., Allison, D. B., Peterson, C. A., Schwiers, M., Day, W. W., & Bowden, C. H. (2012) · The American Journal of Clinical Nutrition

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 716

Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP)

Allison, D. B., Gadde, K. M., Garvey, W. T., Peterson, C. A., Schwiers, M. L., Najarian, T., Tam, P. Y., Troupin, B., & Day, W. W. (2012) · Obesity

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 711

Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia

Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Assessments

Cited by 415

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Nahra, R., Wang, T., Gadde, K. M., Oscarsson, J., Stumvoll, M., Jermutus, L., Hirshberg, B., & Ambery, P. (2021) · Diabetes Care

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 323

Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled Trial

Anderson, J. W., Greenway, F. L., Fujioka, K., Gadde, K. M., McKenney, J., & O'Neil, P. M. (2002) · Obesity Research

Pharmacology and Obesity TreatmentEating Disorders and Behaviors

Cited by 315

Evaluation of phentermine and topiramate versus phentermine/topiramate extended‐release in obese adults

Aronne, L. J., Wadden, T. A., Peterson, C., Winslow, D., Odeh, S., & Gadde, K. M. (2013) · Obesity

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 274

Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment

Noria, S. F., Shelby, R. D., Atkins, K. D., Nguyen, N. T., & Gadde, K. M. (2023) · Current Diabetes Reports

Bariatric Surgery and OutcomesPharmacology and Obesity Treatment

Cited by 223

Bupropion SR vs. Placebo for Weight Loss in Obese Patients with Depressive Symptoms

Jain, A. K., Kaplan, R. A., Gadde, K. M., Wadden, T. A., Allison, D. B., Brewer, E. R., Leadbetter, R. A., Richard, N., Haight, B., Jamerson, B. D., et al. (2002) · Obesity Research

Pharmacology and Obesity TreatmentEating Disorders and Behaviors

Cited by 205

Missing Data in Randomized Clinical Trials for Weight Loss: Scope of the Problem, State of the Field, and Performance of Statistical Methods

Elobeid, M. A., Padilla, M. A., McVie, T., Thomas, O., Brock, D. W., Musser, B., Lu, K., Coffey, C. S., Desmond, R. A., St-Onge, M.-P., et al. (2009) · PLoS ONE

Statistical Methods and Bayesian InferenceStatistical Methods in Clinical Trials

Cited by 158

Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study

Apolzan, J. W., Venditti, E. M., Edelstein, S. L., Knowler, W. C., Dabelea, D., Boyko, E. J., Pi-Sunyer, X., Kalyani, R. R., Franks, P. W., Srikanthan, P., et al. (2019) · Annals of Internal Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 156

Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 128

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Topiramate Controlled Release in the Treatment of Obese Type 2 Diabetic Patients

Rosenstock, J., Hollander, P., Gadde, K. M., Sun, X., Strauss, R., Leung, A., & for the OBD-202 Study Group (2007) · Diabetes Care

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 85

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

The limits and challenges of antiobesity pharmacotherapy

Gadde, K. M., & Atkins, K. D. (2020) · Expert Opinion on Pharmacotherapy

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 65

Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial

Gadde, K. M., Yonish, G. M., Wagner, H. R., Foust, M. S., & Allison, D. B. (2006) · International Journal of Obesity

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 56

Assessing patient beliefs in a clinical trial ofHypericum perforatum in major depression

Bann, C. M., Parker, C. B., Bradwejn, J., Davidson, J. R. T., Vitiello, B., & Gadde, K. M. (2004) · Depression and Anxiety

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 34

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Testosterone supplementation upregulates androgen receptor expression and translational capacity during severe energy deficit

Howard, E. E., Margolis, L. M., Berryman, C. E., Lieberman, H. R., Karl, J. P., Young, A. J., Montano, M. A., Evans, W. J., Rodriguez, N. R., Johannsen, N. M., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism

Hormonal and reproductive studiesMuscle metabolism and nutrition

Cited by 28

Bupropion Treatment of Olanzapine-Associated Weight Gain: An Open-Label, Prospective Trial

Gadde, K. M., Zhang, W., & Foust, M. S. (2006) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentPharmacology and Obesity Treatment

Cited by 24

Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: what mediates improvement?

Kolotkin, R. L., Gadde, K. M., Peterson, C. A., & Crosby, R. D. (2016) · Quality of Life Research

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 24